Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
- Resource Type
- Article
- Source
- In
Allergology International January 2023 72(1):89-99 - Subject
- Language
- ISSN
- 1323-8930